595060 Provided is a pharmaceutical composition, comprising a modified amino acid sequence of Human Immunodeficiency Virus (HIV) trans-activator of transcription, with specific amino acid sequence or a variant thereof with at least 95% sequence identity. The peptides can be used to treat cancer to cause cessation of growth or regression of cancer.